11/19 Yahoo! Finance: ARYX News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Yahoo! Finance: ARYX News - Latest Financial News for ARYx Therapeutics, Inc. Results From Phase 2b Study on Atrial Fibrillation Agent Reviewed at American Heart Association (Business Wire) November 18, 2009 at 12:00 am FREMONT, Calif.----ARYx Therapeutics, Inc. , a biopharmaceutical company, announced that a review of the results of the Phase 2b clinical trial, PASCAL, testing the efficacy and safety of ARYx’s compound for the treatment of atrial fibrillation, budiodarone, was presented today at the American Heart Association meeting in Orlando, Florida.   This email was sent to gatdemit001@gmail.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.